Silicone Irregular Hexagon Pessary Versus Polyvinyl Chloride Ring Pessary for Pelvic Organ Prolapse: Randomised Controlled Trial
International Urogynecology Journal · 2025
DOI: 10.1007/s00192-024-05933-x ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Chin Yong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pelvic Floor Unit, The Royal Women's Hospital, 20 Flemington Rd, Parkville, VIC, 3052, Australia. drchinyong@gmail.com. Hauptthemen laut MEDLINE: Pessaries, Pelvic Organ Prolapse, Silicones, Polyvinyl Chloride. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: Vaginal pessaries are the mainstay of the non-surgical management of pelvic organ prolapse (POP). A flexible silicone irregular hexagonal (SIH) pessary was developed based on the results of a prior vaginal case study. We hypothesised that the SIH pessary would have a higher rate of retention and self-management than the polyvinyl chloride (PVC) pessary. METHODS: This was a prospective non-blinded, randomised controlled trial with institutional review board approval. Eligible participants were randomised and fitted with the assigned pessary. They were reviewed 1 week, 6 months and 1 year after the initial pessary fitting. Participants who returned for follow-up completed the study questionnaires. The primary outcome was success, defined as continued use of the allocated pessary at 6 months. Secondary outcomes included the ability to perform pessary self-care, treatment satisfaction and pessary-related complications. Statistical tests were performed with alpha or statistical significance defined as a p value of ≤ 0.05, two-tailed. RESULTS: A total of 104 participants were randomised, with 52 subjects in each arm. Primary outcome data were analysed using per protocol analysis. Continuing pessary usage at 6 months was 68.1% for the PVC pessary group and 65.1% for the SIH group, with no statistically significant differences between the two groups (p = 0.765). Subjects with SIH were more likely to perform pessary self-care. There were no significant differences in subjects' satisfaction, quality-of-life scores or treatment complications between groups. CONCLUSIONS: The pessary continuation rate between the SIH and the PVC pessary groups was similar at 6 months. Participants with an SIH pessary were more likely to self-manage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pelvic Floor Unit, The Royal Women's Hospital, 20 Flemington Rd, Parkville, VIC, 3052, Australia. drchinyong@gmail.com.
- Epworth HealthCare, Suite 5.2, Level 5, 124 Grey St., East Melbourne, VIC, 3002, Australia. drchinyong@gmail.com.
- Pelvic Floor Unit, The Royal Women's Hospital, 20 Flemington Rd, Parkville, VIC, 3052, Australia.
- Research Development & Governance Unit, Epworth HealthCare, Richmond, VIC, 3121, Australia.
- Department of Health Sciences and Biostatistics, Swinburne University of Technology, Hawthorn, VIC, 3122, Australia.
- Epworth HealthCare, Suite 5.2, Level 5, 124 Grey St., East Melbourne, VIC, 3002, Australia.
ORCID-Profile: Chin Yong
Zitieren
APA
Yong, C., Dune, T., Shaya, R., Cornish, A., McKenzie, D., & Carey, M. (2025). Silicone Irregular Hexagon Pessary Versus Polyvinyl Chloride Ring Pessary for Pelvic Organ Prolapse: Randomised Controlled Trial. International Urogynecology Journal. https://doi.org/10.1007/s00192-024-05933-x
Vancouver
Yong C, Dune T, Shaya R, Cornish A, McKenzie D, Carey M. Silicone Irregular Hexagon Pessary Versus Polyvinyl Chloride Ring Pessary for Pelvic Organ Prolapse: Randomised Controlled Trial. International Urogynecology Journal. 2025. doi:10.1007/s00192-024-05933-x
BibTeX
@article{Yong2025,
author = {Yong, Chin and Dune, Tanaka and Shaya, Rebecca and Cornish, Ann and McKenzie, Dean and Carey, Marcus},
title = {Silicone Irregular Hexagon Pessary Versus Polyvinyl Chloride Ring Pessary for Pelvic Organ Prolapse: Randomised Controlled Trial},
journal = {International Urogynecology Journal},
year = {2025},
doi = {10.1007/s00192-024-05933-x}
}
EUVIMED